Prevalence of orthostatic hypotension in Parkinson’s disease JM Senard, S Rai, M Lapeyre-Mestre, C Brefel, O Rascol, A Rascol, ... Journal of Neurology, Neurosurgery & Psychiatry 63 (5), 584-589, 1997 | 487 | 1997 |
Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure M Galinier, A Pathak, J Fourcade, C Androdias, D Curnier, S Varnous, ... European heart journal 21 (6), 475-482, 2000 | 453 | 2000 |
Clozapine in drug induced psychosis in Parkinson’s disease: a randomised, placebo controlled study with open follow up P Pollak, F Tison, O Rascol, A Destée, JJ Péré, JM Senard, F Durif, ... Journal of Neurology, Neurosurgery & Psychiatry 75 (5), 689-695, 2004 | 359 | 2004 |
The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. O Rascol, U Sabatini, N Fabre, C Brefel, I Loubinoux, P Celsis, JM Senard, ... Brain: a journal of neurology 120 (1), 103-110, 1997 | 249 | 1997 |
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease F Courbon, C Brefel‐Courbon, C Thalamas, MJ Alibelli, I Berry, ... Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003 | 243 | 2003 |
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five … JL Montastruc, O Rascol, JM Senard, A Rascol Journal of Neurology, Neurosurgery & Psychiatry 57 (9), 1034-1038, 1994 | 242 | 1994 |
A study of salivary secretion in Parkinson's disease H Bagheri, C Damase-Michel, M Lapeyre-Mestre, S Cismondo, ... Clinical neuropharmacology 22 (4), 213-215, 1999 | 236 | 1999 |
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan PJ Goadsby, MD Ferrari, J Olesen, LJ Stovner, JM Senard, NC Jackson, ... Neurology 54 (1), 156-156, 2000 | 235 | 2000 |
Deciphering biased-agonism complexity reveals a new active AT1 receptor entity A Saulière, M Bellot, H Paris, C Denis, F Finana, JT Hansen, MF Altié, ... Nature chemical biology 8 (7), 622-630, 2012 | 210 | 2012 |
Exercise training-induced modification in autonomic nervous system: An update for cardiac patients F Besnier, M Labrunee, A Pathak, A Pavy-Le Traon, C Gales, JM Senard, ... Annals of physical and rehabilitation medicine 60 (1), 27-35, 2017 | 186 | 2017 |
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. O Rascol, U Sabatini, C Brefel, N Fabre, S Rai, JM Senard, P Celsis, ... Brain: a journal of neurology 121 (3), 527-533, 1998 | 177 | 1998 |
Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans G Géraud, C Keywood, JM Senard Headache: The Journal of Head and Face Pain 43 (4), 376-388, 2003 | 171 | 2003 |
Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects A Pathak, M Lebrin, A Vaccaro, JM Senard, F Despas Journal of clinical pharmacy and therapeutics 38 (5), 341-349, 2013 | 167 | 2013 |
Orthostatic hypotension in patients with Parkinson’s disease: pathophysiology and management JM Senard, C Brefel-Courbon, O Rascol, JL Montastruc Drugs & aging 18, 495-505, 2001 | 166 | 2001 |
Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. O Rascol, U Sabatini, F Chollet, N Fabre, JM Senard, JL Montastruc, ... Journal of Neurology, Neurosurgery & Psychiatry 57 (5), 567-571, 1994 | 164 | 1994 |
Drug‐induced parkinsonism: a review JL Montastruc, ME Llau, O Rascol, JM Senard Fundamental & clinical pharmacology 8 (4), 293-306, 1994 | 146 | 1994 |
A double‐blind, randomized, comparative study of Dysport® vs. Botox® in primary palmar hyperhidrosis M Simonetta Moreau, C Cauhepe, JP Magues, JM Senard British Journal of Dermatology 149 (5), 1041-1045, 2003 | 140 | 2003 |
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men J Galitzky, C Sengenès, C Thalamas, MA Marques, JM Senard, ... Journal of lipid research 42 (4), 536-544, 2001 | 134 | 2001 |
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease O Rascol, AJ Lees, JM Senard, Z Pirtosek, JL Montastruc, D Fuell Clinical neuropharmacology 19 (3), 234-245, 1996 | 132 | 1996 |
l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, dose-ranging … CJ Mathias, JM Senard, S Braune, L Watson, A Aragishi, JEA Keeling, ... Clinical Autonomic Research 11, 235-242, 2001 | 128 | 2001 |